Shandong Boan Biotechnology Co., Ltd. (HKG: 6955)
Hong Kong
· Delayed Price · Currency is HKD 8.78
-0.24 (-2.66%)
Nov 15, 2024, 11:59 AM HKT
Shandong Boan Biotechnology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 61.81 | -119.38 | -331.75 | -225.42 | -240.54 |
| Depreciation & Amortization | 44.57 | 59.45 | 57.35 | 40.63 | 15.88 |
| Other Amortization | 23.31 | 23.31 | 15.48 | 9.38 | - |
| Loss (Gain) From Sale of Assets | - | - | 0.02 | 0.07 | 0.01 |
| Stock-Based Compensation | 20.7 | 20.64 | 18.48 | 21.28 | - |
| Provision & Write-off of Bad Debts | 0.12 | -0.03 | 0.03 | - | - |
| Other Operating Activities | 25.49 | 15.76 | 5.12 | 7.45 | 10.62 |
| Change in Accounts Receivable | -158.29 | -60.21 | -104.88 | -106.57 | 5 |
| Change in Inventory | -12.13 | -21.66 | -44.79 | -79.17 | -17.12 |
| Change in Accounts Payable | 66.66 | 57.37 | 21.49 | 47.13 | 52.44 |
| Change in Unearned Revenue | 5.53 | 3 | -1.8 | -1 | 1.6 |
| Change in Other Net Operating Assets | -117.72 | 3.17 | 163.42 | 39.95 | -334.63 |
| Operating Cash Flow | -39.94 | -18.57 | -201.84 | -246.28 | -506.72 |
| Capital Expenditures | -64.57 | -67.32 | -81.29 | -107.73 | -25.05 |
| Sale (Purchase) of Intangibles | -337 | -227.43 | -125.09 | -233.52 | -106.22 |
| Investment in Securities | - | - | 100 | -100 | - |
| Other Investing Activities | 0.39 | 1.19 | 5.69 | 8.95 | 112.49 |
| Investing Cash Flow | -401.17 | -293.57 | -100.68 | -432.3 | -18.79 |
| Short-Term Debt Issued | - | 1.37 | - | 2.83 | 886.08 |
| Long-Term Debt Issued | - | 132.85 | 52.98 | - | - |
| Total Debt Issued | 450.1 | 134.22 | 52.98 | 2.83 | 886.08 |
| Short-Term Debt Repaid | - | - | - | - | -659.08 |
| Long-Term Debt Repaid | - | -37.03 | -18.61 | -9.43 | -486.22 |
| Total Debt Repaid | -64.25 | -37.03 | -18.61 | -9.43 | -1,145 |
| Net Debt Issued (Repaid) | 385.85 | 97.19 | 34.37 | -6.6 | -259.22 |
| Issuance of Common Stock | - | - | 189.16 | 1,230 | 798.27 |
| Other Financing Activities | -16.63 | 185.89 | -223.66 | -11.89 | -11.82 |
| Financing Cash Flow | 369.22 | 283.09 | -0.13 | 1,212 | 527.23 |
| Foreign Exchange Rate Adjustments | -5.95 | -2.6 | 4.45 | -5.08 | - |
| Net Cash Flow | -77.85 | -31.65 | -298.21 | 528.07 | 1.73 |
| Free Cash Flow | -104.51 | -85.89 | -283.13 | -354.01 | -531.77 |
| Free Cash Flow Margin | -14.52% | -13.90% | -54.87% | -223.06% | - |
| Free Cash Flow Per Share | -0.21 | -0.17 | -0.57 | -0.74 | -13.55 |
| Cash Interest Paid | 16.63 | 14.11 | 13.05 | 11.6 | 11.82 |
| Levered Free Cash Flow | -516.68 | -77.35 | -484.93 | -801.42 | - |
| Unlevered Free Cash Flow | -503.92 | -68.55 | -476.55 | -794.17 | - |
| Change in Net Working Capital | 203.33 | -204.02 | 147.4 | 385.92 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.